Articles tagged with Insulin
Researchers at UNIGE have developed a new model to study the protein Cx36, which plays a crucial role in insulin production. By analyzing 1040 molecules, they aim to identify those that stimulate or inhibit insulin production, paving the way for new pharmacological treatment strategies for type 2 diabetes.
A UCSF study found that women with diabetes are more likely to report low overall sexual satisfaction compared to non-diabetic women. Insulin-treated diabetic women were at higher risk for lubrication and orgasm complications, while end-organ complications such as heart disease and peripheral neuropathy also impacted sexual function.
A new study published in Diabetologia found that overexpressing the c-Kit receptor increases insulin production and counteracts early diabetic effects of high-fat diets. This breakthrough research provides a promising lead for developing strategies to preserve and restore function to beta cells.
The American College of Physicians developed a free curriculum to train internal medicine residents in identifying and eliminating wasteful treatment options. The high-value, cost-conscious care curriculum focuses on patient cases requiring careful analysis of benefits, harms, costs, and evidence-based decision making.
Researchers found that continuous glucose monitoring devices and insulin pumps improve blood sugar levels and reduce time spent with high levels in patients with type 1 diabetes. These new technologies offer a more convenient alternative to traditional methods, but adherence is key to effectiveness.
Researchers at Duke University Medical Center have found a hormone that stimulates insulin secretion from islet cells and protects them against toxic factors. This discovery could lead to new prevention and treatment options for type 1 and type 2 diabetes.
A UT Southwestern study found that early intensive treatment of type 2 diabetes slows down the progression of the disease by preserving the body's insulin-producing capacity. The intensive treatment regimen was shown to be effective in maintaining steady insulin-producing beta-cell function for three and a half years after diagnosis.
Researchers at UBC successfully reversed diabetes in mice using stem cells, restoring insulin production and reversing the disease. The study re-created the 'feedback loop' that enables insulin levels to automatically rise or fall based on blood glucose levels.
A new study has found that insulin degludec, a long-lasting insulin, reduces the risk of nighttime low blood sugar in elderly diabetic adults compared to insulin glargine. The meta-analysis of phase 3 clinical trials shows that insulin degludec lowers major side effects like hypoglycemia in these patients.
A new study found that an experimental insulin drug, degludec, prevented low blood sugar among diabetic patients more frequently than a popular drug, glargine. Degludec caused 14% fewer low blood sugar incidents overall and 37% less at night compared to glargine.
A new study found that adding liraglutide to insulin therapy improves blood sugar control in obese adults with poorly controlled Type 1 diabetes. Patients also experienced significant weight loss and lower blood pressure.
Researchers found that sitagliptin improves the severity of reactive hypoglycemia by enhancing insulin secretion during meals. This study suggests a novel approach to treating this condition, currently with no medical therapy.
A 9-year study by UCSF researchers found that preventing or better managing diabetes can help prevent cognitive decline. The study linked the severity of diabetes to increased risk of cognitive decline and showed that patients with uncontrolled blood sugar levels suffered faster declines.
Researchers at Oregon Health & Science University and Legacy Health have discovered a method to stabilize liquid glucagon, enabling its use in standard diabetes pumps. This breakthrough could lead to future-generation artificial pancreas systems that dispense both insulin and glucagon for optimal glucose control.
A systematic review found that aggressive blood sugar control can prevent diabetic neuropathy, a disabling condition affecting nerves in the feet and legs. However, the review suggests that optimal target levels for glucose control need to be established to balance benefits and side effects.
In a pilot study, patients with type 2 diabetes who used Almased, a protein-rich meal replacement, lost weight and gained better blood sugar control. After 12 weeks, average insulin doses decreased from 147 to 65 units per day and HbA1c levels dropped by 7.7%.
A study of over 12,500 people in 40 countries found that long-term insulin use does not increase the risk of heart disease or cancer. Participants who received daily basal insulin injections had a lower chance of developing type 2 diabetes even after treatment stopped.
The Hypoglycemia-Hyperglycemia Minimizer (HHM) System successfully detects blood glucose highs and lows, automatically adjusting insulin delivery to safely manage type 1 diabetes. The study's findings lay the groundwork for further clinical trials and a potential game-changer for millions living with the condition.
Scientists at the Toronto General Hospital Research Institute showed that an experimental bariatric surgery can lower blood sugar levels in non-obese rats with type 1 diabetes. The study demonstrated that duodenal-jejunal bypass surgery activates novel nutrient-sensing signals in the jejunum, rapidly lowering blood sugar levels.
A new UCLA study reveals that a high-fructose diet can slow the brain and impair memory and learning. However, adding omega-3 fatty acids to the diet may help minimize this damage.
A clinical study demonstrates the effectiveness of an automated insulin dosage titration system in improving blood glucose control and reducing hypoglycemic events. The system, developed by Hygieia, Inc., automatically updates insulin dosage for patients with type 2 or type 1 diabetes, leading to improved glycemic targets.
A recent study has found that achieving Surgical Care Improvement Project (SCIP) benchmarks for glycemic control among patients undergoing coronary artery bypass graft (CABG) surgery may be irrelevant when perioperative continuous insulin infusion protocols are implemented. The researchers discovered that 6.6% of patients who received ...
A new study aims to determine whether intravenous insulin delivery is more effective than standard shots in improving stroke outcomes. Researchers hope to find ways to lower high blood glucose levels quickly and safely after a stroke, which can worsen brain damage.
Researchers at Ludwig-Maximilians-Universität München have developed a genetically modified strain of pigs whose beta-cells can restore glucose homeostasis and inhibit human-anti-pig immune reaction. This breakthrough could potentially treat type 1 diabetes, overcoming the major barrier of immune rejection.
Researchers have made a breakthrough in treating autoimmune diabetes using genetically modified gut bacteria, increasing the frequency of cured mice compared to traditional methods. The new approach has no adverse side effects and allows the immune system to function normally.
Researchers used public databases to find a novel gene associated with type-2 diabetes, which shows increased activity in fat tissue. The findings suggest that CD44, a cell-surface receptor, plays a major causal role in the disease's development.
A study led by St. Michael's Hospital researchers found that doctors are more reluctant to start patients on insulin due to amplified concerns about side effects. However, the study suggests that better insulin regimens and smart injection methods can make treatment safer and more manageable.
Researchers at Gladstone Institutes discover p75NTR's role in controlling glucose metabolism, finding that blocking this receptor enhances insulin's effectiveness. This breakthrough may lead to new therapies for Type 2 diabetes, a global health problem affecting over 20 million Americans.
A new Joslin study contradicts long-held assumptions about the relationship between hyperinsulinemia and atherosclerosis. Hyperinsulinemia is associated with atherosclerosis in humans due to insulin resistance, but research suggests that excess insulin alone does not cause atherosclerosis.
A new study by Brigham and Women's Hospital found that men with type 2 diabetes treated with insulin without a history of cardiovascular disease are at higher risk for major cardiovascular events. The study showed an accelerated rate of new cardiovascular events in these patients, with a 16% rate over four years.
A study published in PNAS reveals that a deficiency of Mitofusin 2 protein causes insulin resistance and glucose intolerance in mice, highlighting its potential as a target for treating type 2 diabetes. The researchers also note that the protein plays a crucial role in maintaining normal glucose homeostasis.
A new study finds that brain insulin resistance contributes to cognitive decline in Alzheimer's disease, independent of diabetes status. Insulin-sensitizing medicines may have therapeutic potential to correct insulin resistance and slow down or improve cognitive decline.
Researchers found that insulin and nutritional factors help maintain the 'stemness' of blood stem cells in fruit flies. The study's implications include a potential connection between metabolic disruptions and chronic inflammation in humans.
A study by Columbia researchers suggests that intestinal progenitor cells can be coaxed into producing insulin, offering a potential new treatment for type I diabetes. The technique involves knocking out the Foxo1 gene in these cells, which then produce functional insulin-producing cells.
Researchers at Temple University found that high-fat diets alter metabolic pathways in healthy colon tissue, leading to increased colon cancer risk. Epigenetic marks on genes involved in breaking down carbohydrates and lipids were retrained in normal tissue from patients with colon cancer.
A new study published in The Lancet shows that TAK-875, a novel oral medication, significantly improves glycemic control in patients with type 2 diabetes without increasing the risk of hypoglycemia. The results suggest that targeting free fatty acid receptor 1 (FFAR1) may be a viable therapeutic target for treating type 2 diabetes.
TAK-875, a novel oral medication, enhances insulin secretion in a glucose-dependent manner, improving blood sugar control and lowering the risk of hypoglycemia. The study showed significant reductions in HbA1c levels across all TAK-875 doses, with higher efficacy rates compared to glimepiride.
Researchers have overturned a 'textbook' view of liver metabolism, revealing a backup pathway that governs glucose production. The discovery suggests new targets for diabetes drugs and may help bypass the block in insulin action that occurs in Type 2 diabetes.
Researchers at WashU Medicine discovered a potent regulator of insulin sensitivity, protein TBC1D3, which helps improve blood sugar control. Higher levels of TBC1D3 impede feedback loops that normally deactivates insulin signals, keeping the pathway open longer.
A study found that automatic suspension of insulin delivery via insulin pumps reduces the severity and duration of hypoglycemia in individuals with type 1 diabetes. The 'low glucose suspend' feature significantly decreases hypoglycemic episodes, reducing the risk of rebound hyperglycemia.
Researchers at Sanford-Burnham Medical Research Institute discovered that beta cells in the pancreas use taste receptors to sense fructose, a type of sugar. This finding suggests that fructose plays a role in insulin release, amplifying the effect of glucose and potentially impacting metabolic diseases like obesity and diabetes.
Researchers at CRCHUM made a key discovery about insulin secretion regulation in the body, which has important implications for treating Type 2 diabetes. The study mapped the pathway that glucose stimulates to produce insulin and identified genetic processes involved.
Researchers at Cardiff University have discovered a link between killer T-cells and the development of Type 1 diabetes. The study found that killer T-cells can attack and destroy insulin-producing cells in the pancreas, leading to a lack of insulin and high blood sugar.
A new method uses stem cells from cord blood to re-educate a diabetic's own T cells, restarting pancreatic function and reducing the need for insulin. After two to three hours, the re-educated lymphocytes are returned to the patient, improving C-peptide levels and allowing for reduced insulin doses.
New research reveals that insulin stimulates the formation of new elastic fibers in human aortic smooth muscle cells, advancing understanding of diabetic vascular disease. Insulin therapy may help prevent arterial occlusions and improve healing processes in diabetic patients.
The Endocrine Society releases a clinical practice guideline recommending that all hospitalized patients, regardless of diabetes status, have their blood glucose levels tested. This can help prevent complications and mortality associated with hyperglycemia in non-critically ill patients.
Researchers have discovered a protein called Islet Homeostasis Protein (IHoP) that regulates blood sugar levels by balancing insulin and glucagon. The protein's presence helps maintain healthy glucose levels, while its absence leads to increased glucagon and insulin resistance.
The REMOVAL study aims to test whether metformin can prevent or reduce the risk of cardiovascular complications in people with type 1 diabetes. The five-year trial will follow 500 patients and examine the effects of metformin on blood glucose control, treatment satisfaction, and other complications.
Researchers found that restricting carbs two days a week leads to greater weight loss and improved insulin levels compared to daily calorie restriction. This approach may be a more effective way to prevent breast cancer and other diseases, according to the study.
Researchers have found that examining the chin and upper/lower abdomen is an accurate and minimally invasive way to screen for excessive hair growth in women, which can be up to 80% effective. This method has significant implications for diagnosing PCOS and related health risks such as insulin resistance, diabetes, and heart disease.
Researchers discover a compound that prevents Type 1 diabetes in mice and has similar effects on human cells from diabetic patients. The finding signals a new direction in fighting the disease and other autoimmune disorders.
Researchers discovered that insulin signaling converges with nutrient metabolism pathways to regulate lipid synthesis in the liver. The study suggests that multiple pathways are required for insulin-resistant livers to accumulate lipids.
Researchers at Stanford University School of Medicine have identified a key molecular pathway responsible for the decrease in insulin-producing cells with age. Activating this pathway may lead to a new treatment for diabetes, and recent studies have shown promising results in mice.
Scientists at Stanford University have identified a molecular pathway responsible for the decline of beta cell division with age. By manipulating this pathway, they can restore the ability of older beta cells to divide and generate new cells, potentially leading to breakthroughs in treating both type 1 and type 2 diabetes.
A team of researchers has identified Sirt1 as a crucial protein linking caloric restriction to improved insulin action in skeletal muscle. This finding provides new targets for therapeutics to reduce insulin resistance and lower the risk of developing type 2 diabetes.
A study published in PLOS Genetics identified a gene and protein involved in regulating insulin secretion in obese mice. The researchers found that a single amino acid difference in the tomosyn-2 protein destabilizes it, leading to an insufficient insulin response and diabetes susceptibility.
A study has identified a gene, Tomosyn-2, that confers diabetes susceptibility in obese mice by regulating insulin secretion. The protein acts as a brake on insulin release from the pancreas, and its destabilization allows for sufficient insulin production to prevent diabetes.
Scientists at Cold Spring Harbor Laboratory have identified a new approach to treating diabetes and obesity by targeting the PTP1B enzyme, which is crucial in regulating insulin signaling. By oxidizing a specific cysteine residue, the enzyme's activity is temporarily halted, allowing for improved insulin sensitivity.
Researchers at Salk Institute have discovered how a hormone turns on molecular switches inside the pancreas, increasing insulin production. The finding raises the possibility of new designer drugs to help Americans with type 2 diabetes or pre-diabetic insulin resistance.
Patients with uncontrolled diabetes saw faster blood glucose, blood pressure, and cholesterol level control with more frequent primary care visits every two weeks. The study found that doubling the time between physician encounters increased median times to reach treatment targets by 35-87%.